Service de maladies infectieuses et tropicales, CHRU de Caen, 14000 Caen, France; Groupe de recherche sur l'adaptation microbienne (GRAM 2.0), Normandie university, UNICAEN, 14000 Caen, France. Electronic address: verdon-r@chu-caen.fr.
Publications dans "Maladie inflammatoire pelvienne" :
Unité fonctionnelle d'infectiologie régionale, centre hospitalier d'Ajaccio, hôpital Eugénie, boulevard Rossini, 20000 Ajaccio, France; Coordinateur du groupe des recommandations de la Société de pathologie infectieuse de langue française (SPILF), 21, rue Beaurepaire, 75010 Paris, France. Electronic address: bernard.castan@ch-ajaccio.fr.
Publications dans "Maladie inflammatoire pelvienne" :
Service de gynécologie-obstétrique, CHU de Poitiers, 1, rue de la Milétrie, 86000 Poitiers, France. Electronic address: xavier.fritel@univ-poitiers.fr.
Publications dans "Maladie inflammatoire pelvienne" :
Service des maladies infectieuses et tropicales, groupe hospitalier Pellegrin, CHU de Bordeaux, 33000 Bordeaux, France; Infections humaines à mycoplasmes et chlamydiae, USC EA 3671, Institut national de la recherche agronomique, université Bordeaux, 33000 Bordeaux, France; Centre national de référence des infections sexuellement transmissibles bactériennes, CHU de Bordeaux, 33000 Bordeaux, France. Electronic address: charles.cazanave@chu-bordeaux.fr.
Publications dans "Maladie inflammatoire pelvienne" :
Infections humaines à mycoplasmes et chlamydiae, USC EA 3671, Institut national de la recherche agronomique, université Bordeaux, 33000 Bordeaux, France; Centre national de référence des infections sexuellement transmissibles bactériennes, CHU de Bordeaux, 33000 Bordeaux, France; Laboratoire de bactériologie, groupe hospitalier Pellegrin, CHU de Bordeaux, 33000 Bordeaux, France.
Publications dans "Maladie inflammatoire pelvienne" :
Department of TCM Gynecology, Shanghai Pudong New District Gongli Hospital, Second Military Medical University, No.219 Miaopu Road, Pudong New District, Shanghai, 200135, People's Republic of China. tangbixinsh@163.com.
Publications dans "Maladie inflammatoire pelvienne" :
Department of TCM Gynecology, Shanghai Pudong New District Gongli Hospital, Second Military Medical University, No.219 Miaopu Road, Pudong New District, Shanghai, 200135, People's Republic of China.
Publications dans "Maladie inflammatoire pelvienne" :
Department of TCM Gynecology, Shanghai Pudong New District Gongli Hospital, Second Military Medical University, No.219 Miaopu Road, Pudong New District, Shanghai, 200135, People's Republic of China.
Publications dans "Maladie inflammatoire pelvienne" :
Department of TCM Gynecology, Shanghai Pudong New District Gongli Hospital, Second Military Medical University, No.219 Miaopu Road, Pudong New District, Shanghai, 200135, People's Republic of China.
Publications dans "Maladie inflammatoire pelvienne" :
Service de gynécologie-obstétrique, CHU de Poitiers, 1, rue de la Milétrie, 86000 Poitiers, France. Electronic address: amelie.charveriat@chu-poitiers.fr.
Publications dans "Maladie inflammatoire pelvienne" :
Chronic pelvic pain caused by the sequelae of inflammatory pelvic disease is a common clinical condition of pelvic pain in women. At present, the main challenges in its treatment are the limited effec...
Pelvic inflammatory disease (PID) is a widespread female public problem worldwide. And it could lead to infertility, preterm labor, chronic pelvic pain, and ectopic pregnancy (EP) among reproductive-a...
The data of PID and EP among reproductive-aged women (15 to 49 years old) were extracted from the Global Burden of Disease study 2019. The disease burden was assessed by calculating the case numbers a...
In 2019, the ASR of PID prevalence was 53.19 per 100,000 population with a decreasing trend from 1990 (EAPC: - 0.50), while the ASR of EP incidence was 342.44 per 100,000 population with a decreasing ...
PID and EP continue to be public health burdens with a strong correlation despite slightly decreasing trends detected in ASRs globally. Effective interventions and strategies should be established acc...
Chronic pelvic pain (CPP) is the main sequela of pelvic inflammatory disease (PID), with no established treatment. ZY5301 tablets, an effective part preparation extracted from Ajuga decumbens Thunb. (...
To evaluate whether ZY5301 tablets are effective and safe for CPP treatment in women with PID....
This placebo-controlled double-blind, dose-parallel, phase 2 randomized clinical trial was conducted in 9 hospitals in China. Female participants with CPP after PID were enrolled between October 16, 2...
Participants were randomized 1:1:1 to receive ZY5301 300 mg/d, ZY5301 600 mg/d, or placebo orally 3 times a day for 12 weeks....
Visual analog scale (VAS) scores were the main measure used to evaluate the efficacy of ZY5301 in reducing CPP. The evaluation end points for VAS score included changes in mean weekly VAS score from b...
In total, 180 women were randomly assigned, and 177 were included in the efficacy analysis; thus, the full analysis set included 60 participants in the ZY5301 mg/d group (mean [SD] age, 37.4 [8.1] yea...
These findings show that ZY5301 tablet is efficacious for the relief of CPP with acceptable tolerability....
ClinicalTrials.gov Identifier: NCT05460546....
To evaluate the outcome of pelvic inflammatory disease (PID) in patients with endometriosis with and without ovarian endometrioma....
A retrospective cohort study....
A single university-affiliated tertiary center....
A total of 116 patients with endometriosis hospitalized because of PID between the years 2011-2021. Fifty-nine patients with an ovarian endometrioma component were compared with 57 patients with endom...
None....
The primary outcome was severe PID defined as the need for surgical intervention or drainage. Secondary outcomes included tubo-ovarian abscess, number of hospitalization days, a positive cervical bact...
PID in patients with endometrioma was found less likely to respond to antibiotic treatment with increased risk for surgical intervention or drainage compared with endometriosis patients without endome...
Endometrioma patients with PID are less likely to respond to antibiotic treatment and present a higher risk for surgical intervention....
Chronic pelvic inflammatory disease (CPID) is a clinically common gynecological disease. Patients experience chronic pelvic pain and often accompany with emotional dysfunction. However, the impact and...
To explore the differences and correlations among anxiety, depression, and pressure pain threshold (PPT) of acupoints in patients with CPID....
One hundred and forty-seven patients with CPID were recruited. The Visual Analog Scale (VAS) and short-form McGill Pain Questionnaire (SF-MPQ) were used to assess pain. Self-Rating Anxiety Scale (SAS)...
The CPID patients were divided into anxiety-depression group (group A) or nonanxiety-depression group (group B), according to the SAS and SDS scores. Finally, there were 73 patients in group A and 74 ...
Anxiety and depression can affect the PPT of some acupoints in CPID patients, which may provide a reference for acupoint selection for acupuncture treatment of CPID with emotional disorders. This tria...
To describe the incidence and prevalence of pelvic inflammatory disease (PID) and to estimate the risk of cardiometabolic outcomes among women with PID compared to women without PID....
A UK retrospective matched cohort study using data from The Health Improvement Network. To assess cardiometabolic risk, women (aged ≥ 16 years) with PID were compared to matched controls without PID. ...
Among the 715 recorded composite CVD events, the crude incidence rate per 1000 person-years was 1.5 among women with history of PID compared to 1.3 in matched controls. Compared to women without PID (...
There was no excess risk of composite CVD or its subtypes among women with history of PID compared to matched controls. Findings from our study suggest that history of PID was associated with an incre...
Pelvic inflammatory disease (PID) is a common medical condition in women. However, the correlation between exposure to heavy metals, including cadmium (Cd), lead (Pb), manganese (Mn), mercury (Hg), an...
Endometriosis is a multifactorial disease, and inflammation is considered a core pathology. Inflammation related to genital tract infection (GTI) and surgical injury may cause endometriosis. Therefore...
Pelvic inflammatory disease (PID) is a common reproductive health disorder among women of reproductive age. The treatment of PID has slowly evolved, reflecting changing antibiotic susceptibility and a...
To assess the prevalence of chronic endometritis (CE) in patients with infertility and hydrosalpinx or peritubal adhesions and to examine the effects of laparoscopic surgical correction (LSC) on CE an...
This is a retrospective cohort study at private IVF-ET centers. A total of 438 patients, known to have hydrosalpinx (n = 194) or peritubal adhesions (n = 244), and undergoing IVF treatment between Apr...
CE was present in 45.9% of patients (89/194) with hydrosalpinx and 14.3% with peritubal adhesions (35/244). All the 89 patients with CE and hydrosalpinx underwent laparoscopic salpingostomy and/or fim...
CE is prevalent in patients with hydrosalpinx and/or peritubal adhesions who present with infertility. LSC improved CE without antibiotic therapy, improving the CP and LBR after IVF-ET....
